Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Mr. Padraig  McDonnell

Chief Executive Officer, Chief Operating Officer, President & Director

Mr. Henrik  Ancher-Jensen

Senior Vice President and President of Order Fulfillment & Supply Chain

Mr. Rodney  Gonsalves

Principal Accounting Officer, Vice President & Corporate Controller

Mr. John  Kohl

Senior Vice President & Chief Information Officer

Ms. P. Diana Chiu

Vice President, Interim General Counsel & Secretary

Mr. Dominique P. Grau

Senior Vice President of Human Resources & Global Communications

Ms. Allison  Ballmer

Senior Vice President of Strategy & Corporate Development

Ms. Yvonne  Mackie

MD of UK & Ireland Operations and Vice President of Human Resources - Europe

Ms. Jenipher E. Dalton

Senior Vice President, Chief Quality & Regulatory Officer

Mr. Robert W. McMahon

Senior Vice President, Chief Financial Officer and Interim President of Diagnostics & Genomics Group

Nazwa	Kapitalizacja rynkowa
Revvity, Inc.	0M
Genetic Technologies Limited	0M
Standard BioTools Inc.	0M
IDEXX Laboratories, Inc.	0M
China Biotech Services Holdings Limited	0M
Sonic Healthcare Limited	0M
Quest Diagnostics Incorporated	0M
Qiagen N.V.	0M
Amoy Diagnostics Co., Ltd.	0M
WuXi AppTec Co., Ltd.	0M
Shin Nippon Biomedical Laboratories, Ltd.	0M

Agilent Technologies, Inc.

Agilent Technologies, Inc. Lista konkurentów

Główni konkurenci